Tim R. Wagner, Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

PhD Student
University Hospital Heidelberg

PhD student establishing functional single cell interaction experiments on Europe's first Berkeley Lights Lightning platform to develop personalized TCR-transgenic T cell therapies for the treatment of patients with newly diagnosed/relapsed multiple myeloma.

Poster(s):

• P-220: Discovery of tumor-reactive T cell receptors by functional single cell interaction analyses in patients with newly diagnosed multiple myeloma
  Thursday, September 28, 2023

  12:30 PM – 1:30 PM EEST